11th Annual Report in the Dealmakers’ Intentions Series

The Syneos Health Consulting Dealmakers’ Intentions Study is a forward-looking measure of dealmaking activity in the pharmaceutical and biotech industries.  While there are many quality sources of information that look historically at past deal trends, this study offers a prospective view of the partnering and licensing landscape for the year ahead based on a survey of business development professionals on either or both sides of deals, from biopharma companies of all sizes.  This year’s report, the 11th in our series, captures their expectations for deal activity, supply and demand for specific assets and different development stages, and various other factors affecting dealmaking.


Read the 2019 Report Here



Related 2018 Thought Leadership



Contact Us
Call Our Team 

Phone: +1 919 876 9300
Fax: +1 919 876 9360
Toll-Free: +1 866 462 7373


By Neel Patel, Sachin Purwar, David Tannin and Matt Minno